ASCL2 and neoplasm: This PARCB model generates two distinct tumor lineages characterized by either stem-like (POU2F3/ASCL2 subtype) or neuroendocrine features (ASCL1 subtype) that closely resemble the POU2F3 and ASCL1 subtypes seen in clinical SCNCs (10).